Expert patient for NICE Olaparib appraisal - My Ovacome

My Ovacome

18,349 members20,425 posts

Expert patient for NICE Olaparib appraisal

OvacomeSupport profile image
OvacomeSupportPartnerMy Ovacome Team
4 Replies

Dear All

The National Institute for Health and Care Excellence (NICE) are reviewing olaparib for non-BRCA women. The name of the appraisal is: Olaparib for maintenance treatment of recurrent, platinum-sensitive ovarian, fallopian tube and peritoneal cancer that has responded to platinum-based chemotherapy.

As part of the process we make a submission, and we can also nominate someone to be an expert patient to present their experience to the NICE committee. If you have any comments you'd like included in the submission, or if you'd like to be an expert patient at the committee meeting, please let me know. You can comment below or send me a private message.

It would be particularly helpful to hear from anyone who is non-BRCA and has been able to access olaparib through a trial or privately.

If you want to be an expert patient please let me know your email address as I will need to send you paperwork to fill out. Please don't leave your email in the comments below, please either private message me or email me at support@ovacome.org.uk. The committee meeting you will need to attend is on Thursday 16 August 2018 in London.

Best wishes

Anna

Ovacome Support Service Manager

Written by
OvacomeSupport profile image
OvacomeSupport
Partner
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Katmal-UK profile image
Katmal-UK

Hi

Do you only want non-BRAC?

OvacomeSupport profile image
OvacomeSupportPartnerMy Ovacome Team in reply toKatmal-UK

Hello Katmal-UK

No, sorry that wasn't clear. Anyone who's had olaparib who is non-BRCA would be especially relevant for this particular submission but all experiences will help build a picture of olaparib for women with ovarian cancer.

Contributions from those with BRCA mutations will be really helpful, especially as this is the majority of women who have had olaparib.

Best wishes

Anna

Katmal-UK profile image
Katmal-UK in reply toOvacomeSupport

Hi Anna. It probably was clear, it's just been a long day lol. I'll e-mail you my e-mail address once I am home as having been on it, albeit in trial form for over 4 years I might be able to help. Regards. Kathy xx

OvacomeSupport profile image
OvacomeSupportPartnerMy Ovacome Team in reply toKatmal-UK

Hi Kathy

That's great, many thanks.

Best wishes

Anna

Not what you're looking for?

You may also like...

NICE review of first-line olaparib - your comments needed

Hello All NICE are undertaking a Cancer Drugs Fund guidance review for olaparib. The name of the...
OvacomeSupport profile image
Partner

Olaparib experiences - your comments needed

Hello All I've two submissions to make to NICE this month regarding Olaparib availability. If any...
OvacomeSupport profile image
Partner

Rucaparib - NICE appraisal

Dear All The National Institute for Health and Care Excellence (NICE) have contacted Ovacome...
OvacomeSupport profile image
Partner

Olaparib submission to NICE

Hello I know that we have previously requested your comments about olaparib and some of you have...
OvacomeSupport profile image
Partner

Niraparib - NICE appraisal

Dear All The National Institute for Health and Care Excellence (NICE) have contacted Ovacome...
OvacomeSupport profile image
Partner

Moderation team

See all

Top community tags

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.